| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |